The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Episomal vectors for gene expression in mammalian cells
Abstract
An important reason for preferring mammalian cells for heterologous gene expression is their ability to make authentic proteins containing post‐translational modifications similar to those of the native protein. The development of expression systems for mammalian cells has been ongoing for several years, resulting in a wide variety of effective expression vectors. The aim of this review is to highlight episomal expression vectors. Such episomal plasmids are usually based on sequences from DNA viruses, such as BK virus, bovine papilloma virus 1 and Epstein–Barr virus. In this review we will mainly focus on the improvements made towards the usefulness of these systems for gene expression studies and gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“adeno-associated virus (AAV) vectors have shown promise as a gene therapy technology due to their effectiveness and ability to sustain gene expression for several years in certain IRDs [239,240,241].”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [240]
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,102
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R. J., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G. F., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,051
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,625
NEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATION
Gardner, S. D., Field, A., Coleman, D. V., et al. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91776-4 · Cited by 1,517
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,305
Analysis of Mutation in Human Cells by Using an Epstein-Barr Virus Shuttle System
DuBridge, R. B., Tang, P., Hsia, H. C., Leong-Morgenthaler, P.-M., Miller, J. H., & Calos, M. P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.379 · Cited by 1,134
Repeat-induced gene silencing in mammals
Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887
Yates, J., Warren, N., Reisman, D., & Sugden, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3806 · Cited by 670
Viral Vectors for Gene Therapy
Robbins, P. D., & Ghivizzani, S. C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00020-5 · Cited by 529
Rawlins, D. R., Milman, G., Hayward, S. D., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90282-x · Cited by 510
Ustav, M., & Stenlund, A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07967.x · Cited by 449
Reisman, D., Yates, J., & Sugden, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1822 · Cited by 445
The genome of human papovavirus BKV
Seif, I., Khoury, G., & Dhar, R. (1979) · Cell · doi:10.1016/0092-8674(79)90209-5 · Cited by 380
The primary structure and genetic organization of the bovine papillomavirus type 1 genome
Chen, E. Y., Howley, P. M., Levinson, A. D., et al. (1982) · Nature · doi:10.1038/299529a0 · Cited by 368
Reisman, D., & Sugden, B. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.3838 · Cited by 367
Grignani, F., Kinsella, T. J., Mencarelli, A., Valtieri, M., Riganelli, D., Grignani, F., Lanfrancone, L., Peschle, C., Nolan, G. P., & Pelicci, P. G. (1998) · PubMed · Cited by 349
Gene therapy: the first decade
Mountain, A. (2000) · Trends in biotechnology · doi:10.1016/s0167-7799(99)01416-x · Cited by 341
Expression of Epstein‐Barr virus nuclear antigen‐1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 338
Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kölch, W., & Hammerschmidt, W. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6478 · Cited by 319
Gahn, T. A., & Schildkraut, C. L. (1989) · Cell · doi:10.1016/0092-8674(89)90433-9 · Cited by 315
Yates, J. L., & Guan, N. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.483-488.1991 · Cited by 292
In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA
Lowy, D. R., Dvoretzky, I., Shober, R., et al. (1980) · Nature · doi:10.1038/287072a0 · Cited by 284
Lupton, S., & Levine, A. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2533 · Cited by 269
Epstein-Barr virus strategy in normal and neoplastic B cells
Klein, G. O. (1994) · Cell · doi:10.1016/0092-8674(94)90125-2 · Cited by 249
Isolation of human sequences that replicate autonomously in human cells.
Krysan, P. J., Haase, S. B., & Calos, M. P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1026 · Cited by 242
Viral latency and transformation: The strategy of Epstein-Barr virus
Klein, G. (1989) · Cell · doi:10.1016/0092-8674(89)90394-2 · Cited by 239
Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.
Thierry, A. R., Lunardi-Iskandar, Y., Bryant, J., Rabinovich, P., Gallo, R. C., & Mahan, L. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9742 · Cited by 238
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.
Yang, L., Mohr, I., Fouts, E. T., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5086 · Cited by 236
Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C
Legerski, R. J., & Peterson, C. A. (1992) · Nature · doi:10.1038/359070a0 · Cited by 234
Common and unique features of T antigens encoded by the polyomavirus group
Pipas, J. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.3979-3985.1992 · Cited by 231
Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene
Gething, M.-J. H., & Sambrook, J. (1981) · Nature · doi:10.1038/293620a0 · Cited by 231
Characterization of the Bovine Papilloma virus plasmid maintenance sequences
Lusky, M., & Botchan, M. R. (1984) · Cell · doi:10.1016/0092-8674(84)90232-0 · Cited by 222
Bochkarev, A. V., Barwell, J. A., Pfuetzner, R. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81056-9 · Cited by 214
Wysokenski, D. A., & Yates, J. L. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2657-2666.1989 · Cited by 212
Piechaczek, C., Fetzer, C., Baiker, A. E., Bode, J., & Lipps, H. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.426 · Cited by 211
Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
Ambinder, R. F., Mullen, M. A., Chang, Y. N., Hayward, G. S., & Hayward, S. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1466-1478.1991 · Cited by 203
Replication of latent Epstein-Barr virus genomes in Raji cells
Adams, A. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1743-1746.1987 · Cited by 199
Seo, Y. S., Müller, F., Lusky, M., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.702 · Cited by 199
Yang, J., Murphy, T. L., Ouyang, W., & MURPHY, K. M. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02 · Cited by 195
Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes
Maréchal, V., Dehée, A., Chikhi-Brachet, R., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4385-4392.1999 · Cited by 187
Ilves, I., Kivi, S., & Ustav, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4404-4412.1999 · Cited by 184
Skiadopoulos, M. H., & McBride, A. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2079-2088.1998 · Cited by 184
Lehman, C. W., & Botchan, M. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4338 · Cited by 183
Sedman, J., & Stenlund, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00312.x · Cited by 180
Trojan, J., Blossey, B. K., Johnson, T. R., Rudin, S. D., Tykocinski, M., Ilan, J., & Ilan, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4874 · Cited by 177
Ambinder, R. F., Shah, W. A., Rawlins, D. R., et al. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2369-2379.1990 · Cited by 169
Bovine Papilloma Virus Deoxyribonucleic Acid: a Novel Eucaryotic Cloning Vector
Sarver, N., Gruss, P., Law, M.-F., Khoury, G., & Howley, P. M. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.6.486 · Cited by 168
Shire, K., Ceccarelli, D. F. J., Avolio-Hunter, T. M., & Frappier, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2587-2595.1999 · Cited by 167
Alwine, J. C. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1034 · Cited by 167
Park, P. J., Copeland, W. C., Yang, L., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8700 · Cited by 155
P32/TAP, a Cellular Protein That Interacts with EBNA-1 of Epstein–Barr Virus
Wang, Y., Finan, J. E., Middeldorp, J. M., & Hayward, S. D. (1997) · Virology · doi:10.1006/viro.1997.8739 · Cited by 154
Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus.
Pavlakis, G. N., & Hamer, D. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.397 · Cited by 154
Margolskee, R. F., Kavathas, P., & Berg, P. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.7.2837 · Cited by 152
Cis and trans requirements for stable episomal maintenance of the BPV‐1 replicator.
Piirsoo, M., Ustav, E., Mandel, T., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00328.x · Cited by 151
The Initiation of Simian Virus 40 DNA ReplicationIn Vitro
Bullock, P. A., & Simmons, D. T. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082001 · Cited by 150
The Minimal Replicator of Epstein-Barr Virus oriP
Yates, J. L., Camiolo, S. M., & Bashaw, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4512-4522.2000 · Cited by 141
Baiker, A. E., Maercker, C., Piechaczek, C., Schmidt, S. B. A., Bode, J., Benham, C. J., & Lipps, H. J. (2000) · Nature Cell Biology · doi:10.1038/35004061 · Cited by 140
Genetic Evidence that EBNA-1 Is Needed for Efficient, Stable Latent Infection by Epstein-Barr Virus
Lee, M.-A., Diamond, M. E., & Yates, J. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2974-2982.1999 · Cited by 134
Middleton, T. L., & Sugden, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4067-4071.1994 · Cited by 130
Längle-Rouault, F., Patzel, V., Benavente, A., Taillez, M., Silvestre, N., Bompard, A., Sczakiel, G., Jacobs, E. J., & Rittner, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6181-6185.1998 · Cited by 130
Harris, K. F., Christensen, J. B., & Imperiale, M. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2378-2386.1996 · Cited by 129
New host cell system for regulated simian virus 40 DNA replication.
Gerard, R. D., & Gluzman, Y. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3231 · Cited by 124
Functional interactions between papillomavirus E1 and E2 proteins
Berg, M., & Stenlund, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3853-3863.1997 · Cited by 119
Aiyar, A. A., Tyree, C. M., & Sugden, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6394 · Cited by 117
Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus
Sedman, T., Sedman, J., & Stenlund, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2887-2896.1997 · Cited by 110
Remus, R., Kämmer, C., Heller, H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1010-1022.1999 · Cited by 108
Jankelevich, S., Kolman, J. L., Bodnar, J. W., & Miller, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05157.x · Cited by 108
Su, W., Middleton, T. L., Sugden, B., et al. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10870 · Cited by 105
The Linking Regions of EBNA1 Are Essential for Its Support of Replication and Transcription
Mackey, D. M., & Sugden, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3349 · Cited by 102
Lines of BPV‐transformed murine cells that constitutively express influenza virus hemagglutinin.
Sambrook, J., Rodgers, L., White, J., & Gething, M.-J. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb02322.x · Cited by 98
Middleton, T. L., & Sugden, B. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.489-495.1992 · Cited by 95
Stable Episomal Maintenance of Yeast Artificial Chromosomes in Human Cells
Simpson, K. J., McGuigan, A., & Huxley, C. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5117 · Cited by 94
The potential of extrachromosomal replicating vectors for gene therapy
Calos, M. P. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)40049-x · Cited by 91
Human Recombinant α1(V) Collagen Chain
Fichard, A., Tillet, E., Delacoux, F., Garrone, R., & Ruggiero, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30083 · Cited by 90
Choi, T. K., Hollenbach, P. W., Pearson, B. E., et al. (1993) · Nature Genetics · doi:10.1038/ng0693-117 · Cited by 88
Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells
Heinzel, S. S., Krysan, P. J., Calos, M. P., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3738-3746.1988 · Cited by 87
Hsieh, D. J., Camiolo, S. M., & Yates, J. L. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06187.x · Cited by 85
Chromatin Structure of Epstein-Barr Virus
Dyson, P. J., & Farrell, P. J. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-9-1931 · Cited by 84
Human artificial episomal chromosomes for cloning large DNA fragments in human cells
Sun, T.-Q., Fenstermacher, D., & Vos, J. H. (1994) · Nature Genetics · doi:10.1038/ng0994-33 · Cited by 82
A possible contributory role of BK virus infection in neuroblastoma development.
Flægstad, T., Andresen, P. A., Johnsen, J. I., et al. (1999) · PubMed · Cited by 81
Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells
Wade‐Martins, R. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.7.1674 · Cited by 81
Dhar, R., Lai, C., & Khoury, G. (1978) · Cell · doi:10.1016/0092-8674(78)90203-9 · Cited by 78
Little, R. D., & Schildkraut, C. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2893 · Cited by 78
EBNA‐1, the major nuclear antigen of Epstein‐Barr virus, resembles ‘RGG’ RNA binding proteins.
Snudden, D. K., Hearing, J. C., Smith, P. R., Grässer, F. A., & Griffin, B. E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06810.x · Cited by 77
Gillette, T. G., Lusky, M., & Borowiec, J. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8846 · Cited by 76
Mecsas, J. C., & Sugden, B. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000511 · Cited by 75
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin
Frappier, L., & O’Donnell, M. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1786-1790.1992 · Cited by 74
Multiple regions within EBNA1 can link DNAs
Mackey, D. M., Middleton, T. L., & Sugden, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6199-6208.1995 · Cited by 73
Saeki, Y., Wataya‐Kaneda, M., Tanaka, K., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300711 · Cited by 73
Benson, J. D., & Howley, P. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4364-4372.1995 · Cited by 73
Kioussis, D., Wilson, F., Daniels, C. J., et al. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04762.x · Cited by 71
Studies with BK Virus and Monkey Lymphotropic Papovavirus
Yoshiike, K., & Takemoto, K. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2221-4_5 · Cited by 71
Goldsmith, K., Bendell, L., & Frappier, L. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3418-3426.1993 · Cited by 70
Frappier, L., Goldsmith, K., & Bendell, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42220-4 · Cited by 68
Weißhart, K., Taneja, P., & Fanning, E. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9771-9781.1998 · Cited by 68
Control of Cell Cycle Entry and Apoptosis in B Lymphocytes Infected by Epstein-Barr Virus
Spender, L. C., Cannell, E., Hollyoake, M., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4678-4688.1999 · Cited by 66
Mechanisms of Transcriptional Regulation of Cellular Genes by SV40 Large T- and Small T-Antigens
Moens, U. L., Seternes, O. M., Johansen, B., & Rekvig, O. P. (1997) · Virus Genes · doi:10.1023/a:1007962908248 · Cited by 63
Epstein-Barr virus-based vectors that replicate in rodent cells
Krysan, P. J., & Calos, M. P. (1993) · Gene · doi:10.1016/0378-1119(93)90457-e · Cited by 63
Integration of foreign DNA and its consequences in mammalian systems
Doerfler, W., Schubbert, R., Heller, H., Kämmer, C., Hilger-Eversheim, K., Knoblauch, M., & Remus, R. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01061-5 · Cited by 62
Epstein-Barr virus vectors for gene delivery to B lymphocytes.
Robertson, E. S., Ooka, T., & Kieff, E. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11334 · Cited by 61
Epstein-Barr Virus Infection of Human Astrocyte Cell Lines
Menet, A., Speth, C., Larcher, C., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7722-7733.1999 · Cited by 60
Dhar, V. N., & Schildkraut, C. L. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6268 · Cited by 58
Mazda, O., Satoh, E., Yasutomi, K., et al. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00036-7 · Cited by 56
Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
Cachianes, G., Ho, C., Weber, R. F., Williams, S. R., Goeddel, D. V., & Leung, D. W. (1993) · PubMed · Cited by 56
Peterson, C. A., & Legerski, R. J. (1991) · Gene · doi:10.1016/0378-1119(91)90328-9 · Cited by 55
Lei, D., Kunzelmann, K., Koslowsky, T. C., et al. (1996) · PubMed · Cited by 55
Kirchmaier, A. L., & Sugden, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4657-4666.1998 · Cited by 55
Long-term gene expression from autonomously replicating vectors in mammalian cells.
Jg, W., Sh, K., Bulboaca, G. H., et al. (1996) · PubMed · Cited by 54
Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication
Hearing, J. C., Mülhaupt, Y., & Harper, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.694-705.1992 · Cited by 52
Utilization of an Epstein-Barr virus replicon as a eukaryotic expression vector
Young, J. M., Cheadle, C., Foulke, J. S., et al. (1988) · Gene · doi:10.1016/0378-1119(88)90556-2 · Cited by 51
Hirai, H., Satoh, E., Osawa, M., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7776 · Cited by 50
Milanesi, G., Barbanti‐Brodano, G., Negrini, M., et al. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.8.1551-1560.1984 · Cited by 49
Stary, A., & Sarasin, A. R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-7-1679 · Cited by 47
Several different upstream promoter elements can potentiate transactivation by the BPV‐1 E2 protein.
Ham, J., Dostatni, N., Arnos, F., et al. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07843.x · Cited by 47
Tan, B. T., Wu, L., & Berk, A. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7582-7589.1999 · Cited by 46
Kelleher, Z. T., Fu, H., Livanos, E., et al. (1998) · Nature Biotechnology · doi:10.1038/nbt0898-762 · Cited by 46
Safety-modified episomal vectors for human gene therapy
Cooper, M. J., Lippa, M., Payne, J. M., Hatzivassiliou, G., Reifenberg, E., Fayazi, B., Perales, J. C., Morrison, L. J., Templeton, D. J., Piekarz, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6450 · Cited by 46
Ravnan, J. B., Gilbert, D. M., Hagen, K. G. T., et al. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6946-6952.1992 · Cited by 45
Manservigi, R., Grossi, M., Gualandri, R., et al. (1990) · Journal of Virology · doi:10.1128/jvi.64.1.431-436.1990 · Cited by 45
Rice, P. W., & Cole, C. N. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6689-6697.1993 · Cited by 44
Chromosomal Aberrations Induced by BK Virus T Antigen in Human Fibroblasts
Trabanelli, C., Corallini, A., Gruppioni, R., et al. (1998) · Virology · doi:10.1006/viro.1998.9080 · Cited by 44
Earing, J. C., & Levine, A. J. (1985) · Virology · doi:10.1016/0042-6822(85)90205-3 · Cited by 43
Tomiyasu, K.-I., Satoh, E., Oda, Y., Nishizaki, K., Kondo, M., Imanishi, J., & Mazda, O. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9835 · Cited by 42
Westphal, E., Sierakowska, H., Livanos, E., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1863 · Cited by 41
Whitesell, L. J., Rosolen, A., & Neckers, L. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1360 · Cited by 40
Mücke, S., Polack, A., Pawlita, M., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300363 · Cited by 40
Ohe, Y., Zhao, D., Saijo, N., et al. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.3-325 · Cited by 37
Developments in expression cloning
Seed, B. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80094-8 · Cited by 37
Linker scan analysis of the early regulatory region of human papovavirus BK
Deyerle, K. L., & Subramani, S. E. (1988) · Journal of Virology · doi:10.1128/jvi.62.9.3378-3387.1988 · Cited by 36
MacPherson, P. A., Thorner, L., Parker, L. M., et al. (1994) · Virology · doi:10.1006/viro.1994.1544 · Cited by 36
Analysis of the early regulatory region of the human papovavirus BK
Deyerle, K. L., Cassill, J. A., & Subramani, S. E. (1987) · Virology · doi:10.1016/0042-6822(87)90252-2 · Cited by 36
Satoh, E., Osawa, M., Tomiyasu, K.-I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7060 · Cited by 35
Milanesi, G., Barbanti-Brodano, G., Negrini, M., et al. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.8.1551 · Cited by 34
Analysis of origin of DNA replication of human papovavirus BK
Deyerle, K. L., Sajjadi, F. G., & Subramani, S. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.356-365.1989 · Cited by 33
Rolling-circle replication of a high-copy BPV-1 plasmid
Dasgupta, S., Zabielski, J., Simonsson, M., et al. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90485-3 · Cited by 33
Slinskey, A., Barnes, D. W., & Pipas, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6791-6799.1999 · Cited by 33
Studies on the Mechanism of DNA Linking by Epstein-Barr Virus Nuclear Antigen 1
Mackey, D. M., & Sugden, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29873 · Cited by 32
Epstein-Barr virus vectors for gene expression and transfer
Sclimenti, C. R., & Calos, M. P. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80032-3 · Cited by 32
Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1
Avolio-Hunter, T. M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.19.4462 · Cited by 31
Heller, R. A., Song, K. B., Villaret, D. B., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39421-9 · Cited by 31
Satoh, E., Hirai, H., Inaba, T., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01489-6 · Cited by 29
Tsukamoto, H., Wells, D. J., Brown, S., Serpente, P., Strong, P. N., Drew, J., Inui, K., Okada, S., & Dickson, G. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300944 · Cited by 29
Modulation of Bovine Papillomavirus DNA Replication by Phosphorylation of the Viral E1 Protein
Zanardi, T. A., STANLEY, C. M., Saville, B., et al. (1997) · Virology · doi:10.1006/viro.1996.8375 · Cited by 28
Long‐term replication of Epstein‐Barr virus‐derived episomal vectors in the rodent cells
Mizuguchi, H., Hosono, T., & Hayakawa, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01450-2 · Cited by 28
High level transient gene expression in human lymphoid cells by SV40 large T antigen boost
de Chasseval, R., & de Villartay, J. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.2.245 · Cited by 28
Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.
Teo, C. G., & Griffin, B. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8473 · Cited by 26
Zhang, S., & Nonoyama, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2843 · Cited by 25
Mattia, E. D., Ceridono, M., Chichiarelli, S., & D’Erme, M. (1999) · Virology · doi:10.1006/viro.1999.9854 · Cited by 23
A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells
Benedetti, A. D., & Rhoads, R. E. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.8.1925 · Cited by 23
Combinatorial gene expression using multiple episomal vectors
Horlick, R. A., Schilling, A. E., Samama, P., et al. (2000) · Gene · doi:10.1016/s0378-1119(99)00561-2 · Cited by 22
A novel herpesvirus amplicon system for in vivo gene delivery
Wang, S., Di, S., Young, W.-B., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300523 · Cited by 22
Kim, H. Y., Barbaro, B. A., Joo, W. S., Prack, A. E., Sreekumar, K. R., & Bullock, P. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7543-7555.1999 · Cited by 22
Receptor cloning and heterologous expression — towards a new tool for drug discovery
Luyten, W. H. M. L., & Leysen, J. E. (1993) · Trends in biotechnology · doi:10.1016/0167-7799(93)90136-w · Cited by 20
Lutfalla, G., Armbruster, L., Dequin, S., et al. (1989) · Gene · doi:10.1016/0378-1119(89)90005-x · Cited by 20
Oh, S. J., Chittenden, T. W., & Levine, A. J. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.514-519.1991 · Cited by 20
An element of the BK virus enhancer required for DNA replication
Vecchio, A. M. D., Steinman, R. A., & Ricciardi, R. P. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1514-1524.1989 · Cited by 19
Improved expression cloning using reporter genes and Epstein-Barr virus ori-containing vectors
Shen, E. S., Cooke, G. M., & Horlick, R. A. (1995) · Gene · doi:10.1016/0378-1119(95)00038-8 · Cited by 19
Efficient Episomal Expression Vector for Human Transitional Carcinoma Cells
Cooper, M. J., & Miron, S. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.5-557 · Cited by 19
Association of BK and JC Human Polyomaviruses and SV40 with Human Tumors
Monini, P., Lellis, L. D., & Barbanti‐Brodano, G. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_4 · Cited by 19
Horlick, R. A., Sperle, K., Breth, L. A., et al. (1997) · Protein Expression and Purification · doi:10.1006/prep.1996.0701 · Cited by 18
The late promoter of the human papovavirus BK is contained within the early promoter enhancer region
Cassill, J. A., & Subramani, S. E. (1988) · Virology · doi:10.1016/0042-6822(88)90159-6 · Cited by 18
A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers
Evans, T., Brooks, L. J., & Farrell, P. J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300392 · Cited by 17
Manservigi, R., Gualandri, R., Negrini, M., et al. (1988) · Virology · doi:10.1016/0042-6822(88)90080-3 · Cited by 17
Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors
Vidal, M., Wrighton, C. J., Eccles, S. J., et al. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90053-5 · Cited by 16
Stary, A., James, M. R., & Sarasin, A. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3837-3843.1989 · Cited by 16
Mazda, O., Teshigawara, K., Fujimoto, S., et al. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90124-4 · Cited by 16
New BK virus episomal vector for complementary DNA expression in human cells
Grossi, M., Caputo, A., Rimessi, P., et al. (1988) · Archives of Virology · doi:10.1007/bf01310832 · Cited by 16
Uemura, N., Ozawa, K., Tojo, A., et al. (1992) · Blood · doi:10.1182/blood.v80.12.3198.3198 · Cited by 16
Herbig, U., Weißhart, K., Taneja, P., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1099-1107.1999 · Cited by 15
Belt, P. B. G. M., Jongmans, W., de Wit, J., Hoeijmakers, J. H. J., van de Putte, P., & Backendorf, C. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.18.4861 · Cited by 14
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens
Caputo, A., Barbanti‐Brodano, G., Wang, E. W., & Ricciardi, R. P. (1986) · Virology · doi:10.1016/0042-6822(86)90148-0 · Cited by 14
A Two-Plasmid System for Transient Expression of cDNAs in Primate Cells
Asselbergs, F. A. M., & Grand, P. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1128 · Cited by 14
Analysis of a YAC with human telomeres and oriP from Epstein-Barr virus in yeast and 293 cells
Tolmachova, T., Simpson, K. J., & Huxley, C. M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.18.3736 · Cited by 14
Craenenbroeck, K. V., Vanhoenacker, P., Duchau, H., et al. (2000) · Gene · doi:10.1016/s0378-1119(00)00242-0 · Cited by 14
Self-citationGillette, T. G., & Borowiec, J. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5735-5744.1998 · Cited by 13
An Expression System for Mammalian Amino Acid Transporters Using a Stably Maintained Episomal Vector
Matthews, J. C., Aslanian, A. M., McDonald, K., et al. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2432 · Cited by 12
Sexton, C. J., & Pagano, J. S. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5505-5508.1989 · Cited by 11
Replication of bovine papillomavirus vectors in murine cells
Waldenström, M., Schenström, K., Sollerbrant, K., et al. (1992) · Gene · doi:10.1016/0378-1119(92)90091-3 · Cited by 11
Vanhoenacker, P., Gommeren, W., Luyten, W. H. M. L., et al. (1997) · PubMed · Cited by 11
Self-citationThe Use of Epstein–Barr Virus-Based Shuttle Vectors in Rat PC12 Cells
Lindenboim, L., Anderson, D. J., & Stein, R. (1997) · Cellular and Molecular Neurobiology · doi:10.1023/a:1026385206078 · Cited by 10
Garret, M., McHendri-Rinde, B., Spickofsky, N., et al. (1992) · Gene · doi:10.1016/0378-1119(92)90689-m · Cited by 10
Orlowski, R. Z., & Miller, G. G. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.677-686.1991 · Cited by 9
Carstens, C.-P., Gallo, J. C., Maher, V. M., et al. (1995) · Gene · doi:10.1016/0378-1119(95)00466-j · Cited by 9
Lefkowitz, E. J., Pattnaik, A. K., & Ball, L. A. (1990) · Virology · doi:10.1016/0042-6822(90)90334-n · Cited by 9
Strosberg, A. D., & Leysen, J. E. (1991) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(91)90058-d · Cited by 8
Optimized expression of serotonin receptors in mammalian cells using inducible expression systems
Vanhoenacker, P., Gommeren, W., Luyten, W. H. L. M., et al. (1999) · Ghent University Academic Bibliography (Ghent University) · Cited by 8
Self-citationHaase, S. B., Heinzel, S. S., Krysan, P. J., et al. (1989) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(89)90018-3 · Cited by 7
Negrini, M., Rimessi, P., Sabbioni, S., et al. (1991) · PubMed · Cited by 6
Factors affecting amplification of BK virus episomal vectors in human cells
Grossi, M., Caputo, A., Paolini, L., et al. (1988) · Archives of Virology · doi:10.1007/bf01311074 · Cited by 5
Kraus, E., Strong, L. C., & Tainsky, M. A. (1998) · Gene · doi:10.1016/s0378-1119(98)00121-8 · Cited by 4
Molecular Mechanisms of Transformation by Epstein-Barr Virus
Sung, N. S., & Pagano, J. S. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_18 · Cited by 2
Karimi, L., & Crawford, D. H. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_19 · Cited by 2
Reisman, D., & Rotter, V. (1989) · Springer eBooks · doi:10.1007/978-3-642-74197-5_37 · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 10
- Sambrook J., 1988, Vectors for high level expression of proteins in mammalian cells, Focus, 10, 41
- Howley P.M., 1996, Fields Virology, 2045
- Shah K.V., 1996, Fields Virology, 2027
- Cole C.N., 1996, Fields Virology, 1997
- Shah K.V., 1996, Fields Virology, 2077
- Roberts J.M., 1986, Cancer cells 4/DNA Tumor Viruses, 555
- Rickinson A.B., 1996, Fields Virology, 2397
- Kieff E., 1996, Fields Virology, 2343
- Roizman B., 1996, Fields Virology, 2221
- Lupton S., 1986, Cancer Cells 4/DNA Tumor Viruses, 543
Cited by
Sorted by citations
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Lentiviral vectors for ocular gene therapy
Arsenijevic, Y., Berger, A., Udry, F., & Kostic, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081605 · Cited by 47
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
Metadata
- Authors
- Van Craenenbroeck, K., Vanhoenacker, P., & Haegeman, G.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 267
- Issue
- 18
- Pages
- 5665-5678
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W1591316509
- Cited by
- 147
- References
- 194
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 12 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- episomal vectors, mammalian cell expression systems, heterologous expression, BK virus, bovine papillomavirus 1, Epstein-Barr virus, post-translational modification, gene therapy
- MeSH terms
- Animals, BK Virus, Cell Line, Herpesvirus 4, Human, Genetic Vectors, Humans, Models, Genetic, Plasmids, Genetic Therapy, Gene Transfer Techniques, Transgenes, Bovine papillomavirus 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review